Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele R Wing

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
NPJ Precision Oncology|September 17, 2024
FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancerLeah Stein, Karthikeyan Murugesan, Julie W Reeser, et al.
Cancer Research|August 6, 2013
A novel algorithm for simplification of complex gene classifiers in cancerRaphael A Wilson, Ling Teng, Karen M Bachmeyer, et al.
JTO Clinical and Research Reports|September 30, 2021
Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research AutopsyHui-Zi Chen, Russell Bonneville, Anoosha Paruchuri, et al.
Cold Spring Harbor Molecular Case Studies|August 3, 2019
Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma through rapid research autopsyMelanie A Krook, Russell Bonneville, Hui-Zi Chen, et al.
Molecular Cancer Therapeutics|January 9, 2020
Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion CholangiocarcinomaMelanie A Krook, Alexandria Lenyo, Max Wilberding, et al.
Haematologica|May 30, 2024
Myeloid neoplasm with histiocytosis and spleen tyrosine kinase fusion responds to fostamatinibZachary Risch, Benjamin H Kaffenberger, Catherine G Chung, et al.
The Journal of Molecular Diagnostics : JMD|August 14, 2017
Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid TumorsJulie W Reeser, Dorrelyn Martin, Jharna Miya, et al.
Oncotarget|November 5, 2017
Analytic validation and real-time clinical application of an amplicon-based targeted gene panel for advanced cancerMichele R Wing, Julie W Reeser, Amy M Smith, et al.
JCO Precision Oncology|January 9, 2023
Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural VariationsEmily L Hoskins, Eric Samorodnitsky, Michele R Wing, et al.
NPJ Precision Oncology|July 3, 2025
Prevalence and biological impact of clinically relevant gene fusions in head and neck cancersEmily L Hoskins, Raven Vella, Julie W Reeser, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
NPJ Precision Oncology|September 17, 2024
FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancerLeah Stein, Karthikeyan Murugesan, Julie W Reeser, et al.
Cancer Research|August 6, 2013
A novel algorithm for simplification of complex gene classifiers in cancerRaphael A Wilson, Ling Teng, Karen M Bachmeyer, et al.
JTO Clinical and Research Reports|September 30, 2021
Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research AutopsyHui-Zi Chen, Russell Bonneville, Anoosha Paruchuri, et al.
Cold Spring Harbor Molecular Case Studies|August 3, 2019
Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma through rapid research autopsyMelanie A Krook, Russell Bonneville, Hui-Zi Chen, et al.
Molecular Cancer Therapeutics|January 9, 2020
Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion CholangiocarcinomaMelanie A Krook, Alexandria Lenyo, Max Wilberding, et al.
Haematologica|May 30, 2024
Myeloid neoplasm with histiocytosis and spleen tyrosine kinase fusion responds to fostamatinibZachary Risch, Benjamin H Kaffenberger, Catherine G Chung, et al.
The Journal of Molecular Diagnostics : JMD|August 14, 2017
Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid TumorsJulie W Reeser, Dorrelyn Martin, Jharna Miya, et al.
Oncotarget|November 5, 2017
Analytic validation and real-time clinical application of an amplicon-based targeted gene panel for advanced cancerMichele R Wing, Julie W Reeser, Amy M Smith, et al.
JCO Precision Oncology|January 9, 2023
Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural VariationsEmily L Hoskins, Eric Samorodnitsky, Michele R Wing, et al.
NPJ Precision Oncology|July 3, 2025
Prevalence and biological impact of clinically relevant gene fusions in head and neck cancersEmily L Hoskins, Raven Vella, Julie W Reeser, et al.
Pageof 3